glp 1 brain Current understanding and controversy on access of GLP-1 and GLP-1 receptor agonists GLP-1 Medications: A Game Changer

Lack of access often leads patients to switch to less effective alternatives or discontinue treatment entirely. Beyond blood sugar control, Novo Nordisk also states that the Ozempic pill is also approved for reducing the risk of major cardiovascular events, including heart attack, stroke, or death, in adults with type 2 diabetes who are at elevated risk

Arterioscler Thromb Vasc Biol (2020) 40(1):14558

Safety considerations also warrant attention

For example, AOM medications, like Wegovy (AOM semaglutide) or Zepbound (AOM tirzepatide), are approved for weight loss, while ADM medications like Ozempic (ADM semaglutide) and Mounjaro (ADM tirzepatide), are approved for treatment of type 2 diabetes

Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes

How to decide which medication is right for you The choice between Qsymia and a GLP-1 medication is not one you should make alone